-
Published30/04/2025
-
Today22/05/2025
-
Deadline02/06/2025
-
Opening of tenders02/06/2025
Utilities
- indicates text translated automatically in your browsing language
Drug supply - Active substance natalizumab - ATC L04AG03 Text automatically translated in your browsing language Automatically translated
The subject of the contract is the continuous supply of a medicinal product containing the active substance natalizumab – ATC L04AG03. pharmaceutical form 150MG INJ SOL ISP 2X1ML, unit of measurement 2X1ML, pharmaceutical form 300MG INF CNC SOL, 1X15ML, unit of measurement 1X15ML, quantity 1 900 Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.